1-2 of 2
Mathias Schulze
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world incidence of bleeding events in patients with chronic lymphocytic leukemia treated with acalabrutinib +/- obinutuzumab and requiring direct oral anticoagulation

Free
Klaus Fenchel, Eyck von der Heyde, Matthias Zaiss, Thomas Illmer, Mathias Schulze, Stefan Jäger, Sina Schroeder, Daniel Kummer, Patrick Marschner
Journal: Blood
Blood (2025) 146 (Supplement 1): 2724.
https://doi.org/10.1182/blood-2025-2724
Published: 2025
Journal Articles

Ten Year Follow up Analysis of the OSHO Phase III Trial (AML 96) Comparing Different Application Modes of AraC in Patients below 60 Years with Acute Myeloid Leukemia (AML): No Impact of AraCApplication Mode on Remission Rate, Toxicity, Disease-Free Survival or Overall Survival

Free
Cornelia Becker, Rainer Krahl, Antje Schulze, Georg Maschmeyer, Christian Junghanß, Astrid Franke, Norma Peter, Mathias Haenel, Ulrich Wedding, Hans-Heinrich Wolf, Detlev Haehling, Johannes Meran, Gottfried Doelken, Dietrich Kaempfe, Erika Kettner, Norbert Grobe, Axel Florschuetz, Ute Kreibich, Veronika Schirmer, Thomas Ittel, Mathias Schulze, Renate Huhn, Ernst Zschuppe, Bernd Opitz, Michael Assmann, Dirk Hasenclever, Wolfram Poenisch, Werner Helbig, Dietger W. Niederwieser, MD
Journal: Blood
Blood (2008) 112 (11): 2966.
https://doi.org/10.1182/blood.V112.11.2966.2966
Published: 2008